What the treating team is targeting
Proton therapy is radiotherapy delivered with protons rather than X-rays. That single sentence matters at consent because it tells you what the treatment is and what it is not. It is not a guarantee of a better outcome, fewer side effects or a cure. The clinical question is narrower: which area will be treated, and why proton therapy is being proposed for that target rather than another radiotherapy approach.
Ask the treating clinician to describe the target in plain language. Is the aim curative, adjuvant, palliative or something else? Which structures near the target matter most for your case? What alternatives were considered, and what are the known trade-offs? You do not need to make the clinical decision yourself, but you should understand what you are agreeing to before you sign.
If the answer is vague, that is useful information. A consent discussion that cannot name the target or the clinical goal is not ready for your signature. Ask for the specific question to be answered in writing, or ask when it can be answered by the clinician responsible for your radiotherapy plan.
Whether the centre has actually accepted you
An enquiry, a preliminary reply or a records review is not the same as centre acceptance. Proton therapy suitability is assessed individually, and a centre may need to review imaging, pathology, prior treatment records and current clinical status before it can confirm whether it will treat you. Until that confirmation is in writing, treat the plan as provisional.
Ask directly: has the proton centre accepted me as a patient, and if so, on what basis? If the answer is that your case is still under review, ask what information is missing and who will make the final decision. If the answer is that another treatment route is more appropriate, ask for the reasoning so you can discuss it with your local clinician.
This distinction changes your practical decisions. It affects whether you book travel, whether you ask your employer for leave, and whether you pause other arrangements. Do not treat a positive preliminary reply as confirmed access to treatment.
Planning visits, sessions and schedule
Proton therapy usually involves a planning stage before treatment begins. That stage may include imaging, immobilisation, treatment planning and verification. The number of planning visits and the number of treatment sessions depend on your diagnosis, the target and the centre's protocol. These are not universal numbers, and no article can tell you what your schedule will be.
Ask the centre to explain, in writing, what the planning process involves for your case, how many treatment sessions are anticipated, and how the schedule is structured. Ask whether the schedule can change and what would trigger a change. Ask what happens if you need a break, and how that would affect the overall plan.
If you are travelling from overseas, you also need to know how the planning visits and treatment sessions fit together. Can they be completed in one visit, or will there be gaps? What does the centre expect from you between visits? These are administrative and clinical questions for the treating team, not assumptions you should make from another country's practice.
What the consent discussion must cover
Consent is not a formality. It is the point at which the treating clinician should explain the proposed treatment, the expected benefits, the known risks, the alternatives and the consequences of declining. If any of those elements are missing, ask for them before you sign.
Ask what the known risks are for your specific target and your specific health status. Ask what the evidence says about outcomes for your situation, including uncertainty. You are entitled to ask a clinician about evidence-based risk estimates and what they mean for you. No estimate guarantees an individual result.
Ask what would happen if you chose not to have proton therapy, or if you chose a different radiotherapy approach. Ask whether any additional tests or assessments are needed before treatment can start. If the clinician cannot answer a question, ask who can and when.
Follow-up and handover after treatment
Proton therapy does not end when the last session finishes. You need to know what follow-up is planned, who will provide it, and how information will be shared with your local clinicians. Ask the centre to explain its follow-up schedule and what it expects from you after treatment.
If you plan to return home after treatment, ask how the handover will work. What records will be sent, to whom, and when? Who will be responsible for monitoring your response? What symptoms or changes should prompt you to contact a clinician, and which clinician should you contact?
These questions matter because responsibility can become unclear when care moves between countries. The receiving clinician makes independent judgements about your ongoing care. Ask the centre what it will provide to support that handover, and confirm the practical arrangements before you travel.
One practical point often sits behind these questions: the person who treats you and the person who follows you up may not be the same clinician, and they may not be in the same country. Ask the centre to name the clinician who will be responsible for your follow-up after the treatment course ends, and ask whether that person has seen your full treatment record. If the answer is that follow-up will be arranged later, ask when and by whom.
Ask what the centre will send to your local team and in what form. A discharge summary, a treatment plan and imaging are different documents, and your local clinician may need all three to make sense of your response. Ask whether the centre can provide them in a language your local team can read, and how long that takes. Do not assume the handover happens automatically because you asked for it once.
If you are returning to a country where your records are held by a different health system, ask how the two systems will communicate. Who is your named contact at the proton centre after you leave? What is the expected response time if your local clinician has a question? These are practical questions, not clinical ones, and the centre should be able to answer them before you travel.
You should also ask what the centre expects from you during follow-up. Are there specific appointments, scans or blood tests at set intervals? Who arranges them, and what happens if you miss one? If the plan depends on you contacting the centre at certain points, write those points down and confirm them with the treating team.
Finally, ask what would prompt an earlier review. If you develop new symptoms or your local clinician is concerned, who should be contacted first, and how? The answer may differ depending on whether the concern relates to the treated area or to something else. Ask the centre to explain the route clearly, and keep that information with your treatment records.
What to confirm before you agree
Before you consent, you should be able to state, in your own words, what is being treated, why proton therapy is proposed, what the alternatives are, what the known risks are, how many planning visits and treatment sessions are anticipated, and what follow-up will involve. If you cannot, the consent discussion is not finished.
Ask for the key points in writing. A written summary helps you discuss the plan with your local clinician and with anyone supporting you. It also gives you a record of what was explained and what remains uncertain.
An initial enquiry to ChinaSpecialistCare is free. Our team can check the available diagnosis, records and your main question, identify missing information and suggest the relevant next step. This is not a diagnosis or a promise of acceptance. You do not need to buy a proxy consultation to make an initial enquiry. If you want help requesting a specialist appointment or coordinating records, that can be discussed separately.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.